Manufacturer record
Rathi Laboratories (Hindustan) Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Rathi Laboratories (Hindustan) Pvt. Ltd (Bihar) were declared Not of Standard Quality between September 2021 and March 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: AD-204, Adrenaline Bitartrate Injection IP (Reoline Injection) (exp Apr 2026). CDL, Kolkata (CDSCO lab) found it not of standard quality: Appearance of solution, Particulate matter and Description. Listed in the March 2025 alert.
Records by type
3 records linked to Rathi Laboratories (Hindustan) Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Adrenaline Bitartrate Injection IP (Reoline Injection) | Batch AD-204Mfg Nov 2024 · Exp Apr 2026 | Appearance of solution, Particulate matter and DescriptionDescription | CDL, KolkataCDSCO lab | Mar 2025 |
| Calcium Gluconate Injection I.P. 10% w/v (REOCAL) | Batch CG-386Mfg Mar 2024 · Exp Feb 2026 | pH, Particulate matter, Sterility and DescriptionDescription | CDL KolkataCDSCO lab | Jan 2025 |
| Dexamethasone Sodium Phosphate Injection I.P. | Batch DT-72Mfg Nov 2019 · Exp Oct 2021 | AssayAssay | RDTL GuwahatiState lab | Sep 2021 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.